Want endorsement for your educational project? Apply for the UEG Activity Grant until April 5, 2019.
Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology
This is the first UK national guideline to concentrate on acute lower gastrointestinal bleeding (LGIB) and has been commissioned by the Clinical Services and Standards Committee of the BSG.
The BSG and Federation of the Royal Colleges of Physicians of the UK are seeking to appoint a member of the Gastroenterology SCE Board.
Assisted dying is a societal issue, which speaks to our fundamental belief systems as well as our personal and professional ethics...
Nominations should be submitted no later than Wednesday 27 February 2019.
The RCP runs a successful programme of conferences for fellows, members and other healthcare professionals.
Technology appraisal guidance Published: 9 January 2019
Interventional procedures guidance Published: 16 January 2019
The National Guidelines Centre is seeking to recruit a number of Chairs for guideline committees due to start work in 2019.
The award round is now open and will close on Thursday 4th April at 17:00 (GMT).
CSSC Chair Dr Tony Tham provides a brief committee update on a new BSG service development prize.
The BSG is seeking to develop a data analytics group (DAG) for members with an interest in the technical aspects of data capture and analysis.
Policies approved in the November round will be funded from 1 April 2019.
Dr Falk Pharma UK announces the UK launch of Jorveza, the first globally licensed drug approved for the treatment of the immune mediated, chronic and progressive disease of the oesophagus, Eosinophilic Oesophagitis (EoE).
Stress and its causes in UK gastroenterologists: results of a national survey by the British Society of Gastroenterology
This study aimed to evaluate stress and causes of stress in UK gastroenterologists.
Workforce lead Dr Charlotte Rutter has provided the workforce report for 2018.
Delegates will hear from the FIT Pioneer Investigators about the value of FIT as a 'rule-out test' and the latest evidence synthesis supporting it's NPV and important aspects of 'safety netting'.
The December RMOC paper on adalimumab is now available.
An update from the IBD Registry on its work over the last month.
This renewed accreditation is now valid for 5 years until 2023 and continues from the original accreditation which was achieved in 2013.